Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹3.66 Cr₹11 Cr₹15 Cr₹14 Cr₹7.26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA is ₹3.66 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹3.66 Cr
Mar2024₹11 Cr
Mar2023₹15 Cr
Mar2022₹14 Cr
Mar2021₹7.26 Cr

How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹3.66 Cr
-65.52
Mar2024 ₹11 Cr
-30.98
Mar2023 ₹15 Cr
11.78
Mar2022 ₹14 Cr
89.48
Mar2021 ₹7.26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,588.3 Cr -2% 3.3% 37.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2%

3.3%

37.9%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses